Dr. Marshall Strother, MD

Dr. Strother practices at Adventist Health Portland in Portland, Oregon, part of Adventist Health.

Dr. Strother's NPI, 1073931150, was assigned on April 4, 2014. Dr. Strother graduated from Washington University School of Medicine in 2014. Dr. Strother holds Oregon license MD203703.

Dr. Strother's primary practice is Adventist Health Portland, at 10123 Se Market Street, Portland, OR 97216 in Multnomah County. The practice phone is (503) 257-2500.

Dr. Strother's primary practice is Adventist Health Portland in Portland, Oregon, part of Adventist Health. Dr. Strother is also affiliated with OHSU Hospital. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Strother to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Strother practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Strother's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Strother's licenses on file in 2 states: Oregon and Pennsylvania.

CMS data shows 372 Medicare services from Dr. Strother across 12 procedure codes in 2024, for 146 Medicare patients. Medicare paid $39,724 for them.

CMS counts 146 Medicare patients who saw Dr. Strother in 2024. The largest group is 65 to 74, with 78 patients. 68% of them have cancer, and 68% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Strother's median patient age at 72, with 20% women.

In 2024, Dr. Strother wrote 143 Medicare Part D claims for 70 patients. 81% of them were for generic drugs. CMS names the drug for 67 of them, across 3 drugs with 11 or more claims each, at $11,709 in total drug cost. In 2023, CMS named 63 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Strother for performance year 2024, reported as part of a group. Dr. Strother accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Strother as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Strother, published from 2013 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Nephrectomy. Dr. Strother has published most often in Urol Oncol. Dr. Strother's most frequent co-authors are Robert Guy Uzzo, MD, David Yen Tang Chen, MD and Richard Evan Greenberg, MD.

CMS Open Payments shows 35 general payments to Dr. Strother from 12 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 97% of the total. Boston Scientific Corporation paid the most, $653.

Dr. Strother graduated from Washington University School of Medicine in 2014.